Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,485,243
-$1,209,776 QoQ
Shares Held
339,551
+4.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Mar 31, 2020CallValue
$3,956,660
CallShares
90,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. SNY ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in SNY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,485,243 | 339,551 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $15,695,019 | 325,758 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $12,646,992 | 260,978 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,338,503 | 261,409 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,548,792 | 239,056 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $13,507,780 | 243,559 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,458,288 | 237,576 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $14,778,520 | 256,438 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,309,331 | 233,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,422,455 | 235,030 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,514,730 | 231,545 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $11,815,655 | 220,277 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $11,133,690 | 206,562 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $12,497,007 | 229,640 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $11,518,104 | 237,830 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $12,467,517 | 327,920 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,635,277 | 132,626 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $7,378,531 | 143,719 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $7,205,731 | 143,827 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,429,303 | 154,103 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,997,420 | 151,869 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,858,953 | 37,585 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,847,050 | 38,013 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,785,498 | 35,589 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,935,048 | 37,905 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,956,660 | 90,500 | Call | Defined | 2020-05-13 | |
| 2020-03-31 | $1,706,084 | 39,023 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||